1) Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2014;2:e106-16.
2) Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and agerelated macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367-74.
3) Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991;98:1128-34.
4) Lengyel I, Tufail A, Hosaini HA, et al. Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. Invest Ophthalmol Vis Sci 2004;45:2886-92.
6) Spaide RF. Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness. Retina 2018;38:708-16.
7) Corvi F, Souied EH, Capuano V, et al. Choroidal structure in eyes with drusen and reticular pseudodrusen determined by binarisation of optical coherence tomographic images. Br J Ophthalmol 2017;101:348-52.
9) Querques G, Querques L, Forte R, et al. Choroidal changes associated with reticular pseudodrusen. Invest Ophthalmol Vis Sci 2012;53:1258-63.
10) Arnold JJ, Sarks SH, Killingsworth MC, Sarks JP. Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina 1995;15:183-91.
11) Zweifel SA, Imamura Y, Spaide TC, et al. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 2010;117:1775-81.
12) Lee J, Kim M, Lee CS, et al. Drusen subtypes and choroidal characteristics in Asian eyes with typical neovascular age-related macular degeneration. Retina 2020;40:490-8.
13) Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 2001;119:1417-36.
14) Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med 2008;358:2606-17.
15) Kawasaki R, Yasuda M, Song SJ, et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 2010;117:921-7.
16) Yang K, Liang YB, Gao LQ, et al. Prevalence of age-related macular degeneration in a rural Chinese population: the Handan Eye Study. Ophthalmology 2011;118:1395-401.
17) Park SJ, Lee JH, Woo SJ, et al. Age-related macular degeneration: prevalence and risk factors from Korean National Health and Nutrition Examination Survey, 2008 through 2011. Ophthalmology 2014;121:1756-65.
18) Ishiko S, Akiba J, Horikawa Y, Yoshida A. Detection of drusen in the fellow eye of Japanese patients with age-related macular degeneration using scanning laser ophthalmoscopy. Ophthalmology 2002;109:2165-9.
19) Song IS, Cho HY, Lee BR. The comparison of SLO retromode images with conventional fundus photography for the detection of drusen. J Korean Ophthalmol Soc 2011;52:1189-94.
20) Friedman DS, O’Colmain BJ, Muñoz B, et al. Prevalence of age-related macular degeneration in the United Stated. Arch Ophthalmol 2004;122:564-72.
21) Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 2000;107:2224-32.
22) Delcourt C, Diaz JL, Ponton-Sanchez A, et al. Smoking and age-related macular degeneration. The POLA Study. Arch Ophthalmol 1998;116:1031-5.
23) Esparza-Gordillo J, Soria JM, Buil A, et al. Genetic and environ-mental factors influencing the human factor H plasma levels. Immunogenetics 2004;56:77-82.
24) Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 1977;106:33-41.
25) Klein R, Klein BE, KJensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997;104:1804-12.
26) Cougnard-Grégoire A, Delyfer MN, Korobelnik JF, et al. Long-term blood pressure and age-related macular degeneration: the ALIENOR study. Invest Ophthalmol Vis Sci 2013;54:1905-12.
27) Hogg RE, Woodside JV, Gilchirst SE, et al. Cardoivascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 2008;115:1046-52.e2.
28) Chen SJ, Cheng CY, Peng KL, et al. Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan. Invest Ophthalmol Vis Sci 2008;49:3126-33.
32) McGuinness MB, Le J, Mitchell P, et al. Physical activity and age-related macular degeneration: a systematic literature review and meta-analysis. Am J Ophthalmol 2017;180:29-38.
33) Gopinath B, Liew G, Burlutsky G, Mitchell P. Physical activity and the 15-year incidence of age-related macular degeneration. Invest Ophthalmol Vis Sci 2014;55:7799-803.
34) Wu CM, Su FH, Wang WC, et al. Association of chronic hepatitis B virus infection with age-related macular degeneration. Acta Ophthalmol 2019;97:e713-8.
35) Friberg TR, Williamson D. Hepatitis B surface antigen in human subretinal fluid. Am J Ophthalmol 1983;95:712-3.
36) Temel A, Seber E, Gunay M. Detection of hepatitis B surface antigen in aqueous humor. Acta Ophthalmol (Copenh) 1990;68:205-8.
37) Köksal I, Cetinkaya K, Aker F. Hepatitis B surface antigen in tears and aqueous humor. A comparative study of serum hepatitis B surface antigen levels. Ophthalmologica 1992;204:19-22.
38) Singh VK, Kalra HK, Yamaki K, et al. Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats. J Immunol 1990;144:1282-7.
39) Slepova OS, Kushnir VN, Zaĭtseva NS, et al. Clinical and immunological signs of retinal lesions and possibilities of their correction by drugs in patients with chronic diffuse liver diseases of viral etiology and carriers of Australia antigen. Vestn Oftalmol 1994;110:27-9.
41) Abulude OA, Ahmed I, Sadisu FU. Assessment of Hepatitis B Viral infection as a predictor of hepatic enzymes and compounds alteration among antenatal patients. Med Sci (Basel) 2017;5:24.
42) Johnson PT, Betts KE, Radeke MJ, et al. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci USA 2006;103:17456-61.
43) Dewan A, Bracken MB, Hoh J. Two genetic pathways for age-related macular degeneration. Curr Opin Genet Dev 2007;17:228-33.
44) Perkins SJ, Nan R, Li K, et el. Complement factor H-ligand interactions: self- association, multivalency and dissociation constants. Immunobiology 2012;217:281-97.
46) Oh SC. Clinical implication of tumor markers. Korean J Med 2012;83:197-9.
47) Chung S. False-positive elevations in carcinoembryonic antigen levels at a health screening center. Lab Med Online 2019;9:146-52.